NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect

American Journal of Hematology

Volumn 81, Issue 8, 2006, Pages 576-581

  Sawada, Akihisa ^a   Sato, Emiko ^a   Koyama, Maho ^a   Higuchi, Banryoku ^a   Kusuki, Shigenori ^a   Kim, Ji Yoo ^a   Takeshita, Yasufumi ^a   Sakata, Akifumi ^a   Sakata, Naoki ^a   Okamura, Takayuki ^a   Yasui, Masahiro ^a   Inoue, Masami ^a   Kawa, Keisei ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

Epstein Barr virus; KIR; Lymphoproliferative disease; NK cell; Repertoire

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

ADOLESCENT; ALLERGY; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CLONAL VARIATION; EPSTEIN BARR VIRUS; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN CELL; HYDROA VACCINIFORME; LEUKEMIA; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MALE; MOSQUITO ALLERGY; NATURAL KILLER T CELL; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE; VIRUS INFECTION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DRUG EVALUATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; INFANT; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; RECURRENCE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33745983238     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20659     Document Type: Article

References (9)

1. Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988;318:733.
2. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989;84:51.
3. Kawa K. Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease. Int J Hematol 2003;78:24.
4. Kawa K, Okamura T, Yasui M, Sato E, Inoue M. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Crit Rev Oncol Hematol 2002;44:251.
5. Hoffmann T, De Libero G, Colonna M, et al. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol 2000;110:525.
6. Epling-Burnette PK, Painter JS, Chaurasia P, et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 2004;103: 3431.
7. Pascal V, Schleinitz N, Brunet C. et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur J Immunol 2004; 34:2930.
8. Inoue M, Kurahashi H, Ishihara S, et al. Splenic granular lymphocyte proliferation in two patients with chronic active Epstein-Barr virus infection. Igaku-no-Ayumi 1992;162:439 (in Japanese).
9. Chan KC, Zhang J, Chan AT, et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 2003;63:2028.